| 产品编号 | bsm-61521R |
| 英文名称 | Fibulin 5 Recombinant Rabbit mAb |
| 中文名称 | 衰老关键蛋白重组兔单抗 |
| 别 名 | Fibulin-5; FIBL-5; Fibulin 5; FIBL 5; Fibulin5; FIBL5; Dance; Urine p50 protein; UP50; DANCE. |
| 抗体来源 | Rabbit |
| 克隆类型 | Recombinant |
| 克 隆 号 | |
| 交叉反应 | Human,Mouse |
| 产品应用 | WB=1:1000-1:2000
not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
| 理论分子量 | 50 kDa |
| 检测分子量 | 50 |
| 性 状 | Liquid |
| 免 疫 原 | A synthesized peptide derived from human Fibulin 5: 250-448/448 |
| 亚 型 | IgG |
| 纯化方法 | affinity purified by Protein A |
| 缓 冲 液 | 10mM phosphate buffered saline(pH 7.4) with 150mM sodium chloride, 0.05% BSA, 0.02% Proclin300 and 50% glycerol. |
| 保存条件 | Store at 4℃ for short term. Store at -20℃ for long term. Avoid repeated freeze/thaw cycles. |
| 注意事项 | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| PubMed | PubMed |
| 产品介绍 |
Essential for elastic fiber formation, is involved in the assembly of continuous elastin (ELN) polymer and promotes the interaction of microfibrils and ELN.Stabilizes and organizes elastic fibers in the skin, lung and vasculature.Promotes adhesion of endothelial cells through interaction of integrins and the RGD motif. Vascular ligand for integrin receptors which may play a role in vascular development and remodeling. SWISS: Q9UBX5 Gene ID: 10516 Fibulin-5 Fibulin-5亦称为FBLN-5、DANCE或EVEC是细胞外基质蛋白质家族的一员，在组织器官发育、重塑和修复过程中起重要作用，并与内皮细胞相互作用.Fibulin-5广泛分布于富含弹性蛋白的组织, 能直接与原弹性蛋白结合,并将后者锚于细胞表面,这对形成弹性纤维十分关键, 对血管的发育和修复具有重要作用.此外,Fibuljn-5还能促进创口愈合, 与细胞的增殖、运动和侵袭有关 fibulin-5有学者称“皮肤衰老关键蛋白”与皮肤弹性有关的蛋白，对于起着固定细胞外壁、保持肌肤紧绷、 |
| 产品图片 |
Western blot analysis of mouse heart lysate. Using Fibulin 5 (bsm-61521R) monoclonal antibody at 1:1000 dilution and 4°C overnight incubation. Followed by conjugated secondary antibody incubation at r.t. for 60 min.
|
| 1、抗体溶解方法 | |
| 2、抗体修复方式 | |
| 3、常用试剂的配制 | |
| 4、免疫组化操作步骤 | |
| 5、免疫组化问题解答 | |
| 6、Western Blotting 操作步骤 | |
| 7、Western Blotting 问题解答 | |
| 8、关于肽链的设计 | |
| 9、多肽的溶解与保存 | |
| 10、酶标抗体效价测定程序 | |
